Reduced Bcl-2 expression and elevated expression of Caspase-3 and Bax have been used previously as indicators of induced apoptosis of glioma cells and desirable oncologic outcomes of patients with glioma following radiotherapy and/or chemotherapy [28–30]. The gene discussed is BCL2; the disease is glioma.